Cargando…
Newer agents for Helicobacter pylori eradication
Helicobacter pylori infection remains widespread internationally, with a definite morbidity and mortality. The efficacy of standard 7–14 day triple therapies is decreasing, mainly due to increasing primary bacterial resistance to antibiotics. Currently, the most effective treatments are either the s...
Autores principales: | Fiorini, Giulia, Zullo, Angelo, Gatta, Luigi, Castelli, Valentina, Ricci, Chiara, Cassol, Francesca, Vaira, Dino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387829/ https://www.ncbi.nlm.nih.gov/pubmed/22767998 http://dx.doi.org/10.2147/CEG.S25422 |
Ejemplares similares
-
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
por: Gatta, Luigi, et al.
Publicado: (2013) -
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review
por: Saracino, Ilaria Maria, et al.
Publicado: (2021) -
Rescue Therapies for H. pylori Infection in Italy
por: De Francesco, Vincenzo, et al.
Publicado: (2021) -
Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review
por: Buzás, György Miklós, et al.
Publicado: (2023) -
Helicobacter pylori culture: from bench to bedside
por: Zullo, Angelo, et al.
Publicado: (2022)